EY is pleased to announce the winners of the Entrepreneur Of The Year®Award in the Greater Philadelphia Region. This group of bold entrepreneurial leaders was selected by an independent judging panel made up of previous award winners, leading CEOs, investors and other regional business leaders. The winners were unveiled at a special gala on June 14, […]
When Suzie Welsh was 16, she begged her parents to let her travel to Malawi for a mission trip with GAIA, an organization that creates and implements healthcare programs in areas affected by AIDS. She insisted she’d be fine, and they begrudgingly obliged. She returned several weeks later having observed deep poverty, witnessed woman after […]
Grays Ferry’s Pennovation Center is getting a couple of new tenants. Biorealize, makers of a desktop bioprototyping platform, and ZSX Medical, makers of a medical device focusing on minimally-invasive surgery, are the latest companies to join the Penn-run, 58,000-square-foot tech transfer hub. Opened in 2016, the spot houses several elements of Penn’s entrepreneurship ecosystem: from […]
We’re pleased to announce the winners of the 2018 World Changing Ideas Awards. World Changing Ideas, now in its second year, celebrates businesses, policies, and nonprofits that are poised help shift society to a more sustainable and more equitable future. Below, you can see the winners in 12 different categories. Each category was judged by […]
Housed at the University City Science Center’s Digital Health Accelerator, Lia passed a significant hurdle late last year, earning FDA pre-market clearance. The company’s pregnancy test is expected to begin online sales in the U.S. in the middle of this year and in Europe in early 2019. Housed at the University City Science Center’s Digital Health Accelerator, Lia […]
BioBots has a new name and a new software out in the market, continuing to propel the company on its strategy to move beyond being solely the maker of desktop three-dimensional printers and bioinks used to create living tissue. The Philadelphia-based BioBots, founded in 2014 and based at the Pennovation Center, is now known as […]
A suburban Philadelphia animal health company has entered into an exclusive license agreement with the Wistar Institute to further advance a canine melanoma vaccine and other vaccines for cancer and infectious diseases in animals. Financial terms of the deal between Man’s Best Friend Therapeutics (MBFT) of Ambler, Pa., and Wistar, a Philadelphia nonprofit research institute, were […]
Cagent Vascular, a developer of next generation technology for vessel dilatation in cardiovascular disease interventions, including the FDA 510(k) cleared Serranator® Alto PTA Serration Balloon Catheter, announces the completion of enrollment in the First-in-Human PRELUDE Study. The purpose of this prospective, single-arm, multicenter feasibility study is to show the safety and efficacy of the Serranator® […]
Progenra, Inc. announced that it has received the Official Notice of Allowance (dated March 30, 2017) of its patent application entitled “Methods of treating cancer through the inhibition of USP7 and immune system modulation.” The patent, based on work described in a recent publication, is related to a new immune oncology therapy based on the […]
